Dell'Isola Andrea, Vinblad Johanna, Turkiewicz Aleksandra, Kiadaliri Ali, Abbott Allan, Rolfson Ola, Lohmander Stefan L, Jönsson Therese, Englund Martin
Faculty of Medicine, Department of Clinical Sciences Lund, Orthopedics, Clinical Epidemiology Unit, Lund University, Lund, Sweden.
Centre of Registers Västra Götaland, Gothenburg, Sweden; Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Osteoarthritis Cartilage. 2024 Oct;32(10):1308-1318. doi: 10.1016/j.joca.2024.05.005. Epub 2024 May 29.
OBJECTIVES: To investigate how the co-occurrence of diabetes, hypertension and overweight/obesity is associated with pain following an exercise intervention for knee and hip osteoarthritis (OA). METHODS: Register-based cohort study. We included people from the Swedish Osteoarthritis Register who underwent education and exercise for knee or hip OA. Diabetes and hypertension were defined using medical records and dispensation of medication. Body Mass Index (BMI) was used to identify people with overweight (≥25 to <30), and obesity (≥30). We used linear mixed-effect models with patients nested into clinics to estimate the associations between the exposures and pain (Numeric Rating Scale 0-10), adjusting for age, sex, education, and physical activity. RESULTS: We analysed 80,893 patients with knee or hip OA. The accumulation of metabolic conditions was associated with worse pain at baseline and follow-ups. When obesity, hypertension and diabetes coexisted, patients treated for knee OA reported more pain at baseline (adjusted mean pain difference 0.9 [95 %CI: 0.8; 1.0]), 3 months (1.0 [0.9; 1.1]) and 12 months (1.3 [1.1; 1.4]) compared to those without any of the conditions. Similar results were observed for patients treated for hip OA when obesity, hypertension and diabetes coexisted (baseline (0.7 [0.5; 0.8], 3 (0.8[0.6; 1.0]) and 12 months (1.1[0.8; 1.3]). CONCLUSIONS: When diabetes, hypertension and obesity coexist with OA, patients not only experience heightened baseline pain compared to metabolically healthy individuals, but the disparity increases after an education and exercise intervention suggesting that a one-size-fits-all approach may be inadequate in addressing the complex interplay between metabolic health and OA.
目的:探讨糖尿病、高血压和超重/肥胖的共同出现与膝髋关节骨关节炎(OA)运动干预后的疼痛之间的关联。 方法:基于登记的队列研究。我们纳入了瑞典骨关节炎登记处中接受膝或髋OA教育和运动的人群。糖尿病和高血压通过病历和药物配给来定义。体重指数(BMI)用于识别超重(≥25至<30)和肥胖(≥30)的人群。我们使用将患者嵌套在诊所中的线性混合效应模型来估计暴露因素与疼痛(数字评分量表0 - 10)之间的关联,并对年龄、性别、教育程度和身体活动进行了调整。 结果:我们分析了80893例膝或髋OA患者。代谢状况的累积与基线和随访时更严重的疼痛相关。当肥胖、高血压和糖尿病同时存在时,与没有这些状况的患者相比,接受膝OA治疗的患者在基线时报告的疼痛更多(调整后的平均疼痛差异为0.9 [95%CI:0.8;1.0]),3个月时为(1.0 [0.9;1.1]),12个月时为(1.3 [1.1;1.4])。当肥胖、高血压和糖尿病同时存在时,接受髋OA治疗的患者也观察到了类似的结果(基线时为(0.7 [0.5;0.8]),3个月时为(0.8[0.6;1.0]),12个月时为(1.1[0.8;1.3])。 结论:当糖尿病、高血压和肥胖与OA并存时,与代谢健康的个体相比,患者不仅在基线时经历更强烈的疼痛,而且在教育和运动干预后这种差异会增加,这表明一刀切的方法可能不足以应对代谢健康与OA之间复杂的相互作用。
Clin Exp Rheumatol. 2013-10-17
Front Endocrinol (Lausanne). 2024-12-18